NIH-funded research R01 grant

How cholesterol affects insulin-producing cells in the pancreas

Official title: Effects of Cholesterol in Pancreatic Islets

Funded at Seattle Inst for Biomedical/clinical Res · NIH-11064796 · Data updated 2026-11-12

This study is looking at how cholesterol and statin medications might affect the health of insulin-producing cells in the pancreas, which is important for people taking statins to help prevent type 2 diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSeattle Inst for Biomedical/clinical Res
NIH-funded
Lab location1 site (Seattle, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$387,718
NIH project number5R01DK134502-03
Project IDNIH-11064796 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults who are currently taking statins and are at risk of developing type 2 diabetes.

Less likely to help

Patients who are not on statin therapy or those who do not have risk factors for type 2 diabetes may not benefit from this research.

What this research studies

This research investigates the impact of cholesterol, particularly in the context of statin use, on the function and survival of insulin-producing beta cells in the pancreas. The study aims to uncover the mechanisms by which statins may lead to the deterioration of these cells, which is crucial for preventing the onset of type 2 diabetes in patients taking these medications. By focusing on cholesterol transport to mitochondria and its metabolism, the research seeks to fill a significant knowledge gap regarding beta cell health. The findings could lead to new strategies to protect these cells and improve outcomes for patients on statin therapy.

Why it matters

Potential benefit: If successful, this research could help develop strategies to prevent type 2 diabetes in patients using statins.

How similar studies have gone: While the specific mechanisms being studied are less explored, there is existing literature indicating that cholesterol management is critical for beta cell function, suggesting potential for success in this area.

Where this research is happening

  • Seattle Inst for Biomedical/clinical Res
    Seattle, United States
    Active

Researchers

  • Principal investigator: Zraika, Sakeneh — Seattle Inst for Biomedical/clinical Res
  • Study coordinator: Zraika, Sakeneh

Related research

Other NIH-funded projects on the same topics.

  • Military Service–Linked ALS Risk in U.S. Veterans

    This NIH grant investigates why U.S. veterans get ALS more often, by studying military exposures and health records to identify potential risk factors.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11565245

  • Targeting MSUT2 with small molecules to slow tau-related dementia

    Aims to test whether small molecules that block MSUT2’s interaction with RNA can slow or reverse tau-related brain damage in people affected by Alzheimer’s disease and related dementias.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11463459

  • SPOP's role in tau-related brain disease

    Researchers are studying how a protein called SPOP affects tau-related brain damage in Alzheimer's-type conditions, using a small worm model to mirror human disease and look for ways to protect brain cells.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11463455

  • Comparing medicines and weight-loss surgery for liver disease linked to metabolic problems

    This program looks at how two drugs and bariatric surgery work for adults with metabolic dysfunction–associated steatohepatitis (MASH) and liver fibrosis.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11448529

  • Dementia with Lewy Bodies Consortium

    A national research effort to better understand and diagnose Lewy body dementia by studying biomarkers and patient data over time.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11412709

  • Post-TBI Sleep Problems and Alzheimer’s/CTE Brain Changes

    This grant studies whether sleep disruption after a traumatic brain injury increases the risk of Alzheimer’s disease and related brain changes later on, with a focus on people who’ve had mTBI.

    NIH research Seattle Inst for Biomedical/clinical Res · Seattle, United States · NIH-11397349

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.